Trophos Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $532M

Trophos General Information

Description

Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological and cardiac diseases. The company involves screening chemical collections of small molecules on models of sick neurons, using the class of neurons affected in each type of disease.

Contact Information

Website
www.trophos.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Parc scientifique de Luminy
  • Cedex 9, Case 931
  • 13288 Marseille
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Parc scientifique de Luminy
  • Cedex 9, Case 931
  • 13288 Marseille
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trophos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 03-Mar-2015 $532M Completed Generating Revenue
7. Grant 11-Oct-2012 Completed Generating Revenue
6. Grant 26-Mar-2009 Completed Generating Revenue
5. Grant 23-Dec-2008 Completed Generating Revenue
4. Later Stage VC (Series C) 04-Sep-2007 Completed Generating Revenue
3. Grant 04-Sep-2007 Completed Generating Revenue
2. Early Stage VC 01-Apr-2003 $6.91M $22.6M Completed Startup
1. Early Stage VC $15.7M $15.7M Completed Startup
To view Trophos’s complete valuation and funding history, request access »

Trophos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological an
Drug Discovery
Marseille, France
17 As of 2015

Plymouth Meeting, PA
 

Campbell, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trophos Competitors (84)

One of Trophos’s 84 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Vivus Corporate Backed or Acquired Campbell, CA
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Fate Therapeutics Formerly VC-backed San Diego, CA
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 84 competitors. Get the full list »

Trophos Patents

Trophos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2747750-A2 Liposome comprising at least a cholesterol derivative Inactive 25-Aug-2011
AU-2013203682-A1 Liposome comprising at least one cholesterol derivative Active 25-Aug-2011
AU-2013203682-B2 Liposome comprising at least one cholesterol derivative Inactive 25-Aug-2011
CA-2845691-A1 Liposome comprising at least one cholesterol derivative Inactive 25-Aug-2011
FR-2979239-A1 Liposome comprising at least one cholesterol derivative Pending 25-Aug-2011 A61K31/575
To view Trophos’s complete patent history, request access »

Trophos Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trophos Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Amundi Private Equity Funds PE/Buyout Minority
Apicap PE/Buyout Minority
Arch Capital Group Corporation Minority
Crédit Mutuel Impact Asset Manager Minority
Genethon Cure Through Innovation Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

Trophos FAQs

  • When was Trophos founded?

    Trophos was founded in 1999.

  • Where is Trophos headquartered?

    Trophos is headquartered in Marseille, France.

  • What is the size of Trophos?

    Trophos has 17 total employees.

  • What industry is Trophos in?

    Trophos’s primary industry is Drug Discovery.

  • Is Trophos a private or public company?

    Trophos is a Private company.

  • What is the current valuation of Trophos?

    The current valuation of Trophos is .

  • What is Trophos’s current revenue?

    The current revenue for Trophos is .

  • How much funding has Trophos raised over time?

    Trophos has raised $34.2M.

  • Who are Trophos’s investors?

    Amundi Private Equity Funds, Apicap, Arch Capital Group, Crédit Mutuel Impact, and Genethon Cure Through Innovation are 5 of 11 investors who have invested in Trophos.

  • Who are Trophos’s competitors?

    Inovio Pharmaceuticals, Vivus, Sarepta Therapeutics, Fate Therapeutics, and Immunocore Holdings are some of the 84 competitors of Trophos.

  • When was Trophos acquired?

    Trophos was acquired on 03-Mar-2015.

  • Who acquired Trophos?

    Trophos was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process